Axonics (NASDAQ:AXNX – Get Free Report) and BlueRiver Acquisition (NYSE:BLUA – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability. Volatility & Risk Axonics has a beta of 0.58, […]